Cargando…

Infectious complications of immune checkpoint inhibitors in solid organ malignancies

BACKGROUND: Immune checkpoint inhibitors (ICIs) are targeted cancer therapies regarded to have less toxicity than chemotherapy. Immune‐related adverse events (irAEs) of ICIs are well described in the literature but limited data exist on their infectious complications. The objective is to describe th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Justine Abella, Komoda, Kellie, Pal, Sumanta, Dickter, Jana, Salgia, Ravi, Dadwal, Sanjeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704147/ https://www.ncbi.nlm.nih.gov/pubmed/34873868 http://dx.doi.org/10.1002/cam4.4393

Ejemplares similares

1556. Infectious Disease Complications with Use of Checkpoint Inhibitors in Solid Organ Malignancies
por: Komoda, Kellie, et al.
Publicado: (2018)

1760. Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Hematologic Malignancies and Hematopoietic Cell Transplant
por: Ross, Justine Abella, et al.
Publicado: (2019)

2617. Antiviral usage for herpes simplex virus (HSV) detected in bronchoalveolar lavage fluid (BALF) by polymerase chain reaction (PCR) in hematologic malignancy (HM) and solid organ malignancy (SOM) patients with pulmonary infiltrates; impact of infectious disease consultation (IDC) on antiviral stewardship
por: Fu, Cynthia, et al.
Publicado: (2023)

1267. Implementation and Outcomes of Beta-lactam Allergy Management Protocol at a Comprehensive Cancer Center
por: Khalak, Sohanabanu, et al.
Publicado: (2023)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
por: Adashek, Jacob J., et al.
Publicado: (2018)

Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis
por: Meza, Luis, et al.
Publicado: (2023)

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California
por: Salgia, Nicholas J., et al.
Publicado: (2021)

Late‐occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors
por: Sy, Andrew, et al.
Publicado: (2021)

Infectious Complications Following Solid Organ Transplantation
por: Guenette, Alexis, et al.
Publicado: (2019)

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2021)

Value-based genomics
por: Gong, Jun, et al.
Publicado: (2018)

Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic
por: Salgia, Sabrina, et al.
Publicado: (2021)

Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice
por: Pieper, Alexander A, et al.
Publicado: (2021)

Antifungal Resistance and Predictors of Response in Patients with Hematologic Malignancy
por: Wey, Shiuan (Shannon), et al.
Publicado: (2017)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
por: Noronha, Vanita, et al.
Publicado: (2021)

Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell Carcinoma
por: Staehler, Michael, et al.
Publicado: (2021)

Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
por: Yin, Xiaoqiang, et al.
Publicado: (2022)

The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
por: Wong, Chun Wai, et al.
Publicado: (2023)

T-cell response to checkpoint blockade immunotherapies: from fundamental mechanisms to treatment signatures
por: Elliot, Thomas A.E., et al.
Publicado: (2023)

Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
por: Shao, Jun, et al.
Publicado: (2020)

Prevention and Treatment of Infectious Complications After Solid Organ Transplantation in Children
por: Allen, Upton, et al.
Publicado: (2010)

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen
por: Ali, Alaa M., et al.
Publicado: (2017)

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
por: Kasparian, Saro, et al.
Publicado: (2023)

Next Generation Sequencing in metastatic castrate-resistant prostate cancer
por: Adashek, Jacob J., et al.
Publicado: (2018)

Hematologic malignancies following immune checkpoint inhibition for solid tumors
por: van Eijs, Mick J. M., et al.
Publicado: (2022)

Assessment of different mathematical models for diffusion‐weighted imaging as quantitative biomarkers for differentiating benign from malignant solid hepatic lesions
por: Hu, Yao, et al.
Publicado: (2018)

Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial
por: Barata, Pedro C, et al.
Publicado: (2023)

Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies
por: Ma, Jennifer, et al.
Publicado: (2018)

Prognostic value of miR-142 in solid tumors: a meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021)

Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
por: Salgia, Meghan, et al.
Publicado: (2017)

Tivozanib in renal cell carcinoma: a new approach to previously treated disease
por: Salgia, Nicholas J., et al.
Publicado: (2020)

EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity
por: Lucken, Kellie, et al.
Publicado: (2022)

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
por: Zubiri, Leyre, et al.
Publicado: (2021)

Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors
por: Zhao, Dan, et al.
Publicado: (2021)

Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
por: Drobni, Zsofia Dora, et al.
Publicado: (2023)

Immune Checkpoints in Solid Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2023)

Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies
por: Reed, Damon R., et al.
Publicado: (2015)

Asbestos exposure and haematological malignancies: a Danish cohort study
por: Würtz, Else Toft, et al.
Publicado: (2020)

LINC00221 suppresses the malignancy of children acute lymphoblastic leukemia
por: Huang, Man, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4gtiftrrhkunk4pp1739m3p686